{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:19:34Z","timestamp":1767665974129,"version":"3.48.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Res Health Serv Reg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The purpose of this study is to analyse geographic variation in rates of patients and service utilisation for persons with substance use disorders (SUD) across Norwegian hospital catchment areas from 2017 to 2021, considering both outpatient and Inpatient care across substance use diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method and material<\/jats:title>\n                    <jats:p>This registry-based study used data from the Norwegian Patient Registry and Statistics Norway, covering 58,889 unique patients and 121,495 patient-years. Adjusted for age and sex this material yields a national SUD treatment rate of 14.0 per 1,000 over five years, on average 5.8 per year with a declining annual rate from 6.1\u20135.5. Analyses included diagnoses related to alcohol, opioids, cannabis, and other substances, excluding tobacco and opioid maintenance treatment. Three variation measures\u2014Extreme Quotient (EQ), Coefficient of Variation (CV), and Systematic Component of Variation (SCV)\u2014were used to assess disparities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Geographic variation in SUD treatment rates ranged from 3.6 to 11.5 per 1,000 inhabitants reaching a threefold difference between areas (EQ\u2009=\u20093.1). We found that SCV values (8.7\u201323.5) and SCV\n                      <jats:sub>5\u201395<\/jats:sub>\n                      (5.7\u201314.5) for diagnose groups and service type consistently exceeded the threshold of high and extremely high variation. Procurement of private services increased capacity significantly but did not markedly reduce variation. Variation remained extremely high even when the highest and lowest rates were excluded (SCV 13.8, SCV\n                      <jats:sub>5\u201395<\/jats:sub>\n                      11.3).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patient rates in SUD treatment fell every year between 2017\u20132021 and the geographic variation was high to extremely high. Treatment of substance use disorders in Norway may require stronger regional governance to reduce unwarranted variation and ensure equitable access to treatment. Substantial reductions in variation can be achieved by i) redistributing capacity among catchment areas, ii) purchasing fewer and shorter Inpatient stays and iii) increasing outpatient treatment. In addition, such means could dramatically increase patient rates. There is a need for more consistent clinical practices and adjusted capacity for treating specific substance diagnoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s43999-025-00084-y","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:35:09Z","timestamp":1767620109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Geographic variation in the utilisation of specialist healthcare for patients with substance use disorders in Norway: a population-based registry study"],"prefix":"10.1007","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-2646","authenticated-orcid":false,"given":"Haji Kedir","family":"Bedane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen G.","family":"Bramness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per Arne","family":"Holman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"10258","key":"84_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJ Murray","year":"2020","unstructured":"Murray CJ et al (2020) Global burden of 87 risk factors in 204 countries and territories, 1990-2019. A systematic analysis for the Global burden of disease study 2019. Lancet 396(10258):1223\u20131249","journal-title":"Lancet"},{"key":"84_CR2","unstructured":"Bramness JG (2022, Available from: Drug Use Disorders In Norway. https:\/\/www.fhi.no\/he\/folkehelserapporten\/psykisk-helse\/rusmiddellidelser\/?term="},{"key":"84_CR3","doi-asserted-by":"publisher","first-page":"103785","DOI":"10.1016\/j.drugpo.2022.103785","volume":"108","author":"L Gjersing","year":"2022","unstructured":"Gjersing L, Amundsen E (2022) Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010-2018. Int J Drug Policy 108:103785","journal-title":"Int J Drug Policy"},{"key":"84_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jpsychires.2021.10.017","volume":"144","author":"C Crump","year":"2021","unstructured":"Crump C et al (2021) Comparative risk of suicide by specific substance use disorders: a national cohort study. J Psychiatr Res 144:247\u2013254","journal-title":"J Psychiatr Res"},{"issue":"2","key":"84_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/wps.21073","volume":"22","author":"ND Volkow","year":"2023","unstructured":"Volkow ND, Blanco C (2023) Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry 22(2):203\u2013229","journal-title":"World Psychiatry"},{"issue":"8","key":"84_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1360-0443.2004.00783.x","volume":"99","author":"WE McAuliffe","year":"2004","unstructured":"McAuliffe WE, Dunn R (2004) Substance abuse treatment needs and access in the USA: interstate variations. Addic 99(8):999\u20131014","journal-title":"Addiction"},{"issue":"6","key":"84_CR7","doi-asserted-by":"publisher","first-page":"E231574","DOI":"10.1001\/jamahealthforum.2023.1574","volume":"4","author":"SR Lindner","year":"2023","unstructured":"Lindner SR et al (2023) Tate- and county-level geographic variation in opioid use disorder, medication treatment, and opioid-related overdose among Medicaid enrollees. JAMA Hea Forum 4(6):E231574","journal-title":"JAMA Health Forum"},{"key":"84_CR8","volume-title":"Norwegian drug policy in international fora","author":"Norwegian Ministry of Health and Care Services","year":"2009","unstructured":"Norwegian Ministry of Health and Care Services (2009) Norwegian drug policy in international fora"},{"key":"84_CR9","unstructured":"Universitetssykehus O (2025]; Available from: Introduksjon til TSB. 16, May https:\/\/www.oslo-universitetssykehus.no\/fag-og-forskning\/nasjonale-og-regionale-tjenester\/tsb\/introduksjon-til-tsb#statistikk-og-rapporter-om-tsb"},{"key":"84_CR10","unstructured":"Helsedirektoratet (2016) Behandling og rehabilitering av rusmiddelproblemer og avhengighet Nasjonal faglig retningslinje for behandling og rehabilitering av rusmiddelproblemer og avhengighet [Treatment and rehabilitation of substance abuse problems and addiction. National professional guidelines for the treatment and rehabilitation of drug problems and dependence]"},{"key":"84_CR11","unstructured":"Helsedirektoratet (2024 2025 16]; Available from: may) Tverrfaglig spesialisert rusbehandling - d\u00f8gnplasser, behandlingssted. https:\/\/www.helsedirektoratet.no\/statistikk\/samdata-spesialisthelsetjenesten\/tverrfaglig-spesialisert-rusbehandling-dognplasser-behandlingssted"},{"key":"84_CR12","volume-title":"The structure of the healthcare system - how is the Norwegian healthcare system organised?","author":"Norwegian Ministry of Health and Care Services","year":"2024","unstructured":"Norwegian Ministry of Health and Care Services (2024) The structure of the healthcare system - how is the Norwegian healthcare system organised? Government of Norway, Oslo"},{"key":"84_CR13","volume-title":"Norway: health system summary 2024","author":"European Observatory on Health Systems and Policies","year":"2024","unstructured":"European Observatory on Health Systems and Policies (2024) World Health Organization. In: Norway: health system summary 2024. WHO Regi Off Eur"},{"key":"84_CR14","unstructured":"Helsenorge (2024) (Norwegian Directorate of eHealth). You have the right to choose your treatment centre. https:\/\/www.helsenorge.no\/en\/patient-rights\/right-to-choose-treatment-centre\/ . [cited 2024 November 10]; Available from"},{"issue":"1","key":"84_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s43999-023-00025-7","volume":"2","author":"HK Bedane","year":"2023","unstructured":"Bedane HK et al (2023) Geographic variation in the utilisation of specialist healthcare for patients with severe mental illness in Norway: a population-based registry study. Res Health Serv Reg 2(1):9","journal-title":"Res Health Serv Reg"},{"issue":"4117","key":"84_CR16","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1126\/science.182.4117.1102","volume":"182","author":"J Wennberg","year":"1973","unstructured":"Wennberg J, Gittelsohn (1973) Small area variations in healthcare delivery. Sci 182(4117):1102\u20131108","journal-title":"Science"},{"issue":"10","key":"84_CR17","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"von Elm E","year":"2007","unstructured":"von Elm E, Egger M AD, Pocock SJ, G\u00f8tzsche, Vandenbroucke JP (2007) The Strengthening the reporting of observational studies in Epidemiology (strobe) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296","journal-title":"PLoS Med"},{"key":"84_CR18","unstructured":"Norwegian Directorate of Health, The Norwegian patient Registry (NPR) - content and quality documentation. (2023) Norwegian Direct Health, Oslo."},{"key":"84_CR19","unstructured":"Norrwegian Ministry of Health and Care Services (2009) Regulations relating to the Norwegian patient Registry and the Personal health data registries. In: Norwegian ministry of health and Care services. Oslo"},{"key":"84_CR20","unstructured":"Bakken IJ, E.C P, AG et al (2012) Comparison of data from the Norwegian patient register and the cancer Registry of Norway. Clin Epidemiol 4:9\u201316"},{"key":"84_CR21","unstructured":"Huseb\u00f8 AML, H.T O, SL et al (2020) Quality of the Norwegian patient Registry: a review of completeness and validity in somatic and psychiatric care. Scand J Public Health 48(6):611\u2013619"},{"key":"84_CR22","unstructured":"H\u00f8ye A, H.U.K O, SO (2019) Use of the Norwegian patient Registry in health services research: potentials and challenges. Tidsskrift for Den norske legeforening 139(6)"},{"key":"84_CR23","unstructured":"Appleby J, et al, editors (2011) Variations in healthcare: the good, the bad and the inexplicable. London: The King\u2019s Fund."},{"issue":"21","key":"84_CR24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJM198211183072104","volume":"307","author":"K McPherson","year":"1982","unstructured":"McPherson K et al (1982) Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med 307(21):1310\u20131314","journal-title":"N Engl J Med"},{"issue":"1","key":"84_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1472-6963-9-60","volume":"9","author":"B Ib\u00e1\u00f1ez","year":"2009","unstructured":"Ib\u00e1\u00f1ez B et al (2009) Is there much variation in variation? Revisiting statistics of small area variation in health services research. BMC Health Serv Res 9(1):60","journal-title":"BMC Health Serv Res"},{"key":"84_CR26","unstructured":"Cain K, Diehr P (1992) The multiple admission factor (MAF) in Small area variation analysis. UW biostatistics working paper series"},{"key":"84_CR27","unstructured":"Bale M et al Healthcare atlas for mental healthcare and substance abuse treatment; overview and analysis of use of mental healthcare and interdisciplinary specialised addiction services in Norway for the year 2014-2018. 2020. 2021, Helse F\u00f8rde health trust: F\u00f8rde"},{"issue":"1","key":"84_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/acps.12829","volume":"137","author":"FA Torvik","year":"2018","unstructured":"Torvik FA et al (2018) Diagnostic and genetic overlap of three common mental disorders in structured interviews and health registries. Acta Psychiatr Scand 137(1):54\u201364","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"84_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12875-015-0308-8","volume":"16","author":"J Rehm","year":"2015","unstructured":"Rehm J et al (2015) Alcohol dependence and treatment utilisation in Europe - a representative cross-sectional study in primary care. BMC Fam Pract 16(1):90","journal-title":"BMC Fam Pract"},{"issue":"10","key":"84_CR30","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1111\/add.15357","volume":"116","author":"T Mekonen","year":"2021","unstructured":"Mekonen T et al (2021) Treatment rates for alcohol use disorders: a systematic review and meta-analysis. Addiction 116(10):2617\u20132634","journal-title":"Addiction"},{"issue":"1","key":"84_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40273-024-01442-3","volume":"43","author":"P Chaudhary","year":"2025","unstructured":"Chaudhary P et al (2025) Universal Health coverage of opioid agonist treatment in Norway: an equity-adjusted economic evaluation. PharmacoEconomics 43(1):93\u2013107","journal-title":"PharmacoEconomics"},{"key":"84_CR32","unstructured":"Prop (2015) 15 S, Opptrappingsplanen for rusfeltet (2016-2020). The escalation plan for the drug field"},{"key":"84_CR33","volume-title":"Incidence of SARS-CoV-2 and all-cause mortality in persons with co-occurring substance use disorder and mental illness during the pandemic: a Norwegian cohort study","author":"M Leonhardt","year":"2023","unstructured":"Leonhardt M, Bramness JG, Lien L (2023) Incidence of SARS-CoV-2 and all-cause mortality in persons with co-occurring substance use disorder and mental illness during the pandemic: a Norwegian cohort study. Soc Psychiatry Psychiatr Epidemiol"},{"key":"84_CR34","volume-title":"Jama health Forum","author":"JL Dieleman","year":"2025","unstructured":"Dieleman JL et al (2025) Drivers of variation in healthcare spending across us counties. In: JAMA health Forum. American Medical Association"},{"key":"84_CR35","doi-asserted-by":"publisher","first-page":"1356342","DOI":"10.3389\/frhs.2024.1356342","volume":"4","author":"M Haugum","year":"2024","unstructured":"Haugum M, Iversen HH, Bjertnaes O (2024) National surveys of patient experiences with addiction services in Norway: do employees use the results in quality initiatives and are results improving over time? Front Health Serv 4:1356342","journal-title":"Front Health Serv"},{"key":"84_CR36","unstructured":"OsloMet -Oslo MU (2021, Available from: Oslo, the divided city - a deep socioeconomic divide splits Oslo from east to west. https:\/\/www.oslomet.no\/en\/research\/featured-research\/oslo-divided-city"},{"key":"84_CR37","unstructured":"Oslo kommune (2024) Bydelsfakta - statistikk om befolkning, levek\u00e5r og boforhold i ulike deler av Oslo"},{"key":"84_CR38","doi-asserted-by":"crossref","unstructured":"Skogen JC et al (2019) Sociodemographic characteristics associated with alcohol consumption and alcohol-related consequences, a latent class analysis of the Norwegian WIRUS screening study. BMC public health 19(1):1364","DOI":"10.1186\/s12889-019-7648-6"},{"key":"84_CR39","doi-asserted-by":"crossref","unstructured":"Breidablik HJ et al (2024) Variasjonar i psykisk helsevern-status og forklaringsfaktorar. Tidsskr For Nor Psykologforening= J Norw Psychological Assoc 61(9)","DOI":"10.52734\/AMIA6472"},{"key":"84_CR40","doi-asserted-by":"crossref","unstructured":"PLOS Medicine Editors (2013) The paradox of mental health: over-treatment and under-recognition. PLoS medicine 10(5):e1001456","DOI":"10.1371\/journal.pmed.1001456"},{"issue":"3","key":"84_CR41","doi-asserted-by":"publisher","first-page":"e0003330","DOI":"10.1371\/journal.pgph.0003330","volume":"5","author":"A Endalamaw","year":"2025","unstructured":"Endalamaw A et al (2025) Universal health coverage-exploring the what, how, and why using realist review. PLoS Glob Public Health 5(3):e0003330","journal-title":"PLoS Glob Public Health"},{"issue":"4","key":"84_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/1455072520941977","volume":"37","author":"H Klingemann","year":"2020","unstructured":"Klingemann H (2020) Successes and failures in treatment of substance abuse: treatment system perspectives and lessons from the European continent*. Nord Stud Alcohol Drugs 37(4):323\u2013337","journal-title":"Nord Stud On Alcohol And Drugs"},{"key":"84_CR43","unstructured":"Norwegian Institute of Public Health (2023, Available from: Patient care for people with substance abuse and mental illness. https:\/\/www.helsebiblioteket.no\/innhold\/omsorgsbiblioteket\/engelsk\/patient-care-for-people-with-substance-abuse-and-mental-illness"},{"key":"84_CR44","volume-title":"Prevention, harm reduction and treatment policy 2024-2025","author":"Ministry of Health and Care Services","year":"2024","unstructured":"Ministry of Health and Care Services (2024, Norwegian Ministry of Health and Care Services (Prevention, harm reduction and treatment policy 2024-2025. Oslo, HOD"},{"key":"84_CR45","unstructured":"Norwegian Directorate of Health Specialised Health services act and Regional Health authority Responsibilities. 2023, Norwegian Directorate of Health. Oslo, Helsedirektoratet"}],"container-title":["Research in Health Services &amp; Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43999-025-00084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43999-025-00084-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43999-025-00084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:03:47Z","timestamp":1767665027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43999-025-00084-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["84"],"URL":"https:\/\/doi.org\/10.1007\/s43999-025-00084-y","relation":{},"ISSN":["2730-9827"],"issn-type":[{"type":"electronic","value":"2730-9827"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this research, aggregated information at the levels of hospital referral areas were used and patient level data was not used. Thus, this registry-based study did not require ethical approval from an ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have no conflict of interest in this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}